Spotex
Spotex
Approved
Approval ID
d0485ea3-984d-3193-e053-2995a90a078f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 26, 2023
Manufacturers
FDA
Pella Pharmaceuticals Co. Ltd
DUNS: 562370925
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Erythromycin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code82160-126
Product Classification
G
Generic Name
Erythromycin
Product Specifications
Route of AdministrationTOPICAL
Effective DateDecember 26, 2023
FDA Product Classification
INGREDIENTS (1)
ERYTHROMYCINActive
Quantity: 1200 mg in 30 g
Code: 63937KV33D
Classification: ACTIB